Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
The PMHNP job market remains extremely favorable in 2026 with demand outpacing supply by 3-to-1 in most regions. Average salaries have risen to...
If you’re a new-grad PMHNP searching for post-graduate support, you’ve probably encountered three terms used almost interchangeably: residency...
Insurance audits are increasing for psychiatric providers in 2026, targeting documentation quality, medical necessity, and E/M code accuracy.
Ketamine and esketamine are reshaping treatment-resistant depression care, with expanded indications and new delivery models emerging in 2026.
If you’ve typed “how to find a PMHNP mentor” into a search bar, you already know the answer isn’t simple. Unlike medical residencies where mentorship is...
With the X-waiver eliminated, all DEA-licensed PMHNPs can now prescribe buprenorphine for opioid use disorder without special certification.
Imposter syndrome affects up to 70% of new PMHNPs, creating self-doubt that can stall clinical growth and lead to burnout.
Launching a psychiatric private practice as a PMHNP in 2026 requires navigating credentialing, insurance paneling, EHR selection, and business formation.
New 2026 consensus guidelines revise lithium renal monitoring protocols, recommending eGFR checks every 3 months for the first year and introducing...
The FDA has streamlined clozapine REMS requirements for 2026, reducing ANC monitoring frequency for established patients while maintaining safety...